Airfinity US RSV vaccine market estimate cut by 64% from $4.7bn to $1.7bn a year by 2030 following recommendations for single lifetime shot for elderly people London, England, July 24, 2024 (GLOBE NEWSWIRE) -- Airfinity has reduced its sales projections for vaccines against Respiratory Syncytial Virus (RSV) for older adults in the US from $4.7bn per year...

Global surge in infectious diseases as over 40 countries report outbreaks 10-fold over pre-pandemic levels London, England, June 14, 2024 (GLOBE NEWSWIRE) -- Global surge in infectious diseases as over 40 countries report outbreaks 10-fold over pre-pandemic levels New analysis by Airfinity and...

Democracies are better at managing pandemics than autocracies, according to a new study by Airfinity London, England, May 15, 2024 (GLOBE NEWSWIRE) -- Democratic nations tended to fare better during the pandemic with fewer excess deaths than autocratic nations, according to new analysis by...

Airfinity launches world’s first obesity data and analytics platform London, England, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Today, Airfinity is launching the world’s first data and analytics platform dedicated to the breakthrough obesity treatments market.  ...